Thursday, September 17, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Researchmalarialeishmaniasispeptide-nanoparticlesdrug-delivery

Review maps peptide nanoplatforms for malaria and leishmaniasis targeting

ChemMedChem authors survey peptide-enabled nanocarriers for intracellular parasite delivery and possible diagnostic translation.

PR
By Priya Raman · Science Reporter
Sep 17 08:52 ETSource: ChemMedChem

The wire

  1. 01ChemMedChem review covers peptide-enabled nanoplatforms for malaria and leishmaniasis, from intracellular targeting to diagnostics.
  2. 02Peptide targeting could improve delivery against intracellular parasites in neglected tropical diseases.
  3. 03Clinical translation remains unproven; no trial data reported in the review.

From the source

Peptide-Enabled Nanoplatforms for Malaria and Leishmaniasis: From Intracellular Targeting to Translational Diagnostic Perspectives

ChemMedChem · 2026 Sep 28 · Carnero Canales CS, Lunardi Yagi AC, Reis TC et al.

Read at pubmed.ncbi.nlm.nih.gov
Source URL https://pubmed.ncbi.nlm.nih.gov/42750372/